Top Markets
#1 Black Phoenix Black Phoenix +355.57%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.07%
#4 Akedo Akedo +52.17%
#5 Acurast Acurast +34.63%
#6 BasedHype BasedHype +25.79%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.14%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +21.13%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.89%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
9 Meters Biopharma, Inc. 9 Meters Biopharma, Inc.

9 Meters Biopharma, Inc.

NMTR
Classement en actions #40890
Based in Raleigh, North Carolina, 9 Meters Biopharma, Inc. operates as a... Based in Raleigh, North Carolina, 9 Meters Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. Its core mission is to innovate treatments for individuals suffering from rare digestive conditions, gastrointestinal disorders with inadequate therapeutic options, and other severe debilitating ailments. The company's pipeline features several promising drug candidates. Larazotide, an 8-amino acid peptide, is currently in a Phase 3 clinical trial for the treatment of celiac disease and is also being assessed in a Phase IIa study for multi-system inflammatory syndrome. Another key asset, Vurolenatide, a long-acting injectable glucagon-like peptide-1, is undergoing Phase 2 clinical trials to address short bowel syndrome. Additionally, 9 Meters Biopharma is advancing other compounds, including NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist intended for the prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody designed to target specific obesity disorders; and NM-004, a double-cleaved mesalamine combined with an immunomodulator, slated for rare and/or orphan indications.
Prix de l'action
$0.0169
Dernière synchronisation: 2023-08-21
Capitalisation boursière
$66.40K
Changement (1 jour)
4.32%
Changement (1 an)
0.00%
Pays
US
Échange 9 Meters Biopharma, Inc. (NMTR)

Catégorie

Healthcare
Historique du prix de l'action pour 9 Meters Biopharma, Inc. (NMTR)
Prix de clôture le plus élevé : $0.02 le 2023-08-01

Prix de clôture le plus bas : $686.06 le 2016-07-01
Historique du prix de l'action de 9 Meters Biopharma, Inc. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 -98.82%
2022 -92.87%
2021 7.49%
2020 28.30%
2019 -72.54%
2018 -60.37%
2017 -60.70%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $524.45 32.46%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $863.27 33.51%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE